BioXcel Therapeutics Inc (BTAI)

[lettruthringout]

OnkosXcel Therapeutics subsidiary gives BioXcel more options

1) Sell OnkosXcel to suitor interested in cancer treatment franchise

2) Sell Igalmi franchise to suitor interested in schizophrenia/bi-polar/Alzheimer treatment

3) Sell OnkosXcel and Igalmi to different suitors

4) License Igalmi to Europe/Asian partners and focus on domestic market for both BXCL501 and BXCL701

-------------------------------------------------------------

From today's SEC filing

Notwithstanding the foregoing, the Credit Agreement permits OnkosXcel Therapeutics LLC (“OnkosXcel”), the Company’s subsidiary formed to develop BXCL701 and related assets (together with OnkosXcel Employee Holdings LLC and their respective subsidiaries, the “BXCL701 Subsidiaries”) to receive third-party investment or transfer all or substantially all of their assets to an unaffiliated third party, in each case subject to terms and conditions set forth in the Credit Agreement,